|
Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome |
|
|
|
Titel: |
Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome |
Auteur: |
Ghanem, Hady Cornelison, A. Megan Garcia-Manero, Guillermo Kantarjian, Hagop Ravandi, Farhad Kadia, Tapan Cortes, Jorge O'Brien, Susan Brandt, Mark Borthakur, Gautam Jabbour, Elias |
Verschenen in: |
Clinical lymphoma myeloma and leukemia |
Paginering: |
Jaargang 13 (2013) nr. S2 pagina's 6 p. |
Jaar: |
2013 |
Inhoud: |
|
Uitgever: |
Elsevier Inc. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|